Chemo Pharma Laboratories Past Earnings Performance
Past criteria checks 5/6
Chemo Pharma Laboratories has been growing earnings at an average annual rate of 19.7%, while the Diversified Financial industry saw earnings growing at 19.5% annually. Revenues have been declining at an average rate of 2.3% per year. Chemo Pharma Laboratories's return on equity is 10.8%, and it has net margins of 90%.
Key information
19.7%
Earnings growth rate
19.8%
EPS growth rate
| Diversified Financial Industry Growth | 18.9% |
| Revenue growth rate | -2.3% |
| Return on equity | 10.8% |
| Net Margin | 90.0% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Chemo Pharma Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15 | 13 | 0 | 0 |
| 30 Sep 23 | 10 | 8 | 0 | 0 |
| 30 Jun 23 | 11 | 9 | 1 | 0 |
| 31 Mar 23 | 3 | 0 | 1 | 0 |
| 31 Dec 22 | 5 | 3 | 1 | 0 |
| 30 Sep 22 | 7 | 5 | 2 | 0 |
| 30 Jun 22 | 3 | 0 | 4 | 0 |
| 31 Mar 22 | 8 | 6 | 2 | 0 |
| 31 Dec 21 | 8 | 4 | 2 | 0 |
| 30 Sep 21 | 5 | 2 | 2 | 0 |
| 30 Jun 21 | 6 | 2 | 3 | 0 |
| 31 Mar 21 | 5 | 3 | 1 | 0 |
| 31 Dec 20 | 7 | 2 | 1 | 0 |
| 30 Sep 20 | 7 | 3 | 1 | 0 |
| 30 Jun 20 | 9 | 3 | 4 | 0 |
| 31 Mar 20 | 10 | 4 | 2 | 0 |
| 31 Dec 19 | 11 | 6 | 2 | 0 |
| 30 Sep 19 | 11 | 6 | 2 | 0 |
| 30 Jun 19 | 10 | 4 | 6 | 0 |
| 31 Mar 19 | 8 | 2 | 2 | 0 |
| 31 Dec 18 | 8 | 2 | 2 | 0 |
| 30 Sep 18 | 10 | 3 | 2 | 0 |
| 30 Jun 18 | 11 | 5 | 3 | 0 |
| 31 Mar 18 | 11 | 1 | 2 | 0 |
| 31 Dec 17 | 60 | 45 | 2 | 0 |
| 30 Sep 17 | 57 | 42 | 1 | 0 |
| 30 Jun 17 | 56 | 42 | 1 | 0 |
| 31 Mar 17 | 56 | 47 | 1 | 0 |
| 31 Dec 16 | 5 | -14 | 1 | 0 |
| 30 Sep 16 | 5 | -14 | 1 | 0 |
| 30 Jun 16 | 5 | -14 | 1 | 0 |
| 31 Mar 16 | 5 | -14 | 1 | 0 |
| 31 Dec 15 | 5 | 2 | 1 | 0 |
| 30 Sep 15 | 5 | 2 | 1 | 0 |
| 30 Jun 15 | 5 | 2 | 1 | 0 |
| 31 Mar 15 | 5 | 3 | 1 | 0 |
| 31 Dec 14 | 4 | 3 | 1 | 0 |
| 30 Sep 14 | 4 | 3 | 1 | 0 |
| 30 Jun 14 | 4 | 3 | 1 | 0 |
| 31 Mar 14 | 4 | 2 | 1 | 0 |
| 31 Dec 13 | 2 | 3 | 1 | 0 |
| 30 Sep 13 | 2 | 3 | 1 | 0 |
| 30 Jun 13 | 2 | 2 | 1 | 0 |
Quality Earnings: 506365 has high quality earnings.
Growing Profit Margin: 506365's current net profit margins (90%) are higher than last year (63.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 506365's earnings have grown by 19.7% per year over the past 5 years.
Accelerating Growth: 506365's earnings growth over the past year (303.4%) exceeds its 5-year average (19.7% per year).
Earnings vs Industry: 506365 earnings growth over the past year (303.4%) exceeded the Diversified Financial industry 14.7%.
Return on Equity
High ROE: 506365's Return on Equity (10.8%) is considered low.